C12Y 204/01152
4-galactosyl-n-acetylglucosaminide 3-alpha-l-fucosyltransferase
Official title: 4-Galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase (2.4.1.152)
C12Y204/01152 (4-galactosyl-n-acetylglucosaminide 3-alpha-l-fucosyltransferase) appears on 5 US grants and 24 published applications in this corpus.
Search patents in C12Y- Granted patents
- 5
- Published applications
- 24
- Assignees
- 13
- Inventors
- 50
- Latest grant
- 15 Jul 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2020 | 0 | 1 |
| 2021 | 0 | 1 |
| 2022 | 1 | 4 |
| 2023 | 0 | 5 |
| 2024 | 3 | 5 |
| 2025 | 1 | 4 |
| 2026 | 0 | 4 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Oligosaccharide production in yeast cells expressing an ABC transporter protein15 Jul 2025US 12,359,234 B2Amyris, Inc.
- Production of a mixture of neutral non-fucosylated oligosaccharides by a cell3 Sep 2024US 12,077,788 B2Inbiose N.V.
- Glyco-engineered immunization antigens2 Jul 2024US 12,023,373 B2Expres2ion Biotechnologies ApS
- Compositions and methods for enforcing fucosylation of lactosaminyl glycans in human cells with alpha(1,3)-fucosyltransferases26 Mar 2024US 11,939,616 B2The Brigham and Women S Hospital, Inc.
- Method for producing 3-fucosyllactose using Corynebacterium glutamicum29 Nov 2022US 11,512,318 B2Advanced Protein Technologies Corp.
- Chemoenzymatic method for the detection of cell-cell proximity interaction and isolation of tumor-specific antigen reactive t cells for immune therapy8 Oct 2026US 2026/0308537 A1The Scripps Research Institute
- Oligosaccharide production in yeast12 Mar 2026US 2026/0071245 A1Amyris, Inc.
- Production of a mixture of neutral fucosylated oligosaccharides by a cell26 Feb 2026US 2026/0055436 A1Inbiose N.V.
- Anti-tumor antibodies29 Jan 2026US 2026/0028420 A1Immunome, Inc.
- Production of an oligosaccharide mixture by a cell27 Nov 2025US 2025/0361477 A1Inbiose N.V.
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.